Neuromuscular relaxants in the neonate

Area of Science:

• Critical Care Medicine
• Neonatology
• Pharmacology

Background:

• Neuromuscular blockade is a common adjunct to mechanical ventilation in critically ill patients.
• Its use in premature infants with respiratory distress is debated for preventing barotrauma and intracranial hemorrhage.
• Neuromuscular blocking agents are now frequently used in neonatal intensive care units.

Purpose of the Study:

• To review the pharmacology of neuromuscular blocking agents.
• To discuss the indications and consequences of their use in neonates.
• To highlight potential side effects and recent changes in practice.

Main Methods:

• Literature review of neuromuscular blockade in neonatal care.
• Discussion of pharmacological properties of neuromuscular blocking agents.
• Analysis of clinical indications, outcomes, and adverse events.

Main Results:

• Neuromuscular blockade is utilized to facilitate mechanical ventilation in neonates.
• Evidence suggests potential benefits in reducing barotrauma and intracranial hemorrhage.
• Newer, shorter-acting agents are becoming available, necessitating practice review.

Conclusions:

• Understanding the pharmacology and clinical application of neuromuscular blocking agents is crucial for neonatal care.
• Careful consideration of risks and benefits is warranted with their use.
• Current practices should be updated to reflect the introduction of novel agents.